Suppr超能文献

Toll 样受体 4 触发促进了 DC-SIGN 靶向抗原的细胞溶质途径,用于 MHC Ⅰ类分子的呈递。

Toll-Like Receptor 4 Triggering Promotes Cytosolic Routing of DC-SIGN-Targeted Antigens for Presentation on MHC Class I.

机构信息

Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, Netherlands.

Centre for Specialized Nutrition, Danone Research, Wageningen, Netherlands.

出版信息

Front Immunol. 2018 Jun 14;9:1231. doi: 10.3389/fimmu.2018.01231. eCollection 2018.

Abstract

DC-SIGN is an antigen uptake receptor expressed on dendritic cells (DCs) with specificity for glycans present on a broad variety of pathogens and is capable of directing its cargo to MHC-I and MHC-II pathways for the induction of CD8 and CD4 T cell responses, respectively. Therefore, DC-SIGN is a very promising target for the delivery of antigen for anti-cancer vaccination. Although the endocytic route leading to MHC-II presentation is characterized to a large extent, the mechanisms controlling DC-SIGN targeted cross-presentation of exogenous peptides on MHC-I, are not completely resolved yet. In this paper, we used imaging flow cytometry and antigen-specific CD8 T cells to investigate the intracellular fate of DC-SIGN and its cargo in human DCs. Our data demonstrates that immature DCs and toll-like receptor 4 (TLR4) stimulated DCs had similar internalization capacity and were both able to cross-present antigen targeted DC-SIGN. Interestingly, simultaneous triggering of TLR4 and DC-SIGN on DCs resulted in the translocation of cargo to the cytosol, leading to proteasome-dependent processing and increased CD8 T cell activation. Understanding the dynamics of DC-SIGN-mediated uptake and processing is essential for the design of optimal DC-SIGN-targeting vaccination strategies aimed at enhancing CD8 T cell responses.

摘要

树突细胞(DC)特异性免疫球蛋白样凝集素 2(DC-SIGN)是一种抗原摄取受体,能够识别多种病原体表面的糖基,并将其携带的抗原分别递呈给 MHC-I 类和 MHC-II 类途径,从而诱导 CD8 和 CD4 T 细胞应答。因此,DC-SIGN 是用于癌症疫苗投递的一个很有前途的靶点。尽管靶向 MHC-II 递呈的内吞途径在很大程度上已经得到了阐明,但控制 DC-SIGN 靶向递呈外源性肽段至 MHC-I 的机制尚未完全解决。在本文中,我们使用成像流式细胞术和抗原特异性 CD8 T 细胞来研究 DC-SIGN 及其携带物在人树突状细胞内的命运。我们的数据表明,未成熟的 DC 和 TLR4 刺激的 DC 具有相似的内化能力,并且都能够交叉递呈靶向 DC-SIGN 的抗原。有趣的是,同时激活 TLR4 和 DC-SIGN 会导致货物向细胞质易位,从而引发蛋白酶体依赖性加工,并增强 CD8 T 细胞的激活。了解 DC-SIGN 介导的摄取和加工的动力学对于设计旨在增强 CD8 T 细胞应答的最佳 DC-SIGN 靶向疫苗策略至关重要。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验